BackI-Mab Overview

I-Mab Other Current Liabilities

Latest other current liabilities for IMAB: $6.5M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$6.49M
50.93% YoYΔ $-6.74M vs prior year quarter

Peer trimmed avg / median

Loading

I-Mab Other Current Liabilities History

Loading

I-Mab vs. peers: Other Current Liabilities Comparison

Loading

I-Mab Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

I-Mab (IMAB) FAQ

As of the most recent data (June 2025), IMAB shows a other current liabilities of $6.5M. That compares with $13M in the prior-year period — down 50.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMAB's other current liabilities is now $6.5M (was $13M) — a 50.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether I-Mab is outperforming or lagging.

Tracking IMAB's other current liabilities over time shows whether I-Mab is scaling, shrinking, or reshaping that part of the business. The current reading is $6.5M That compares with $13M in the prior-year period — down 50.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has I-Mab's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $6.5M) with ownership activity and broader fundamentals.

I-Mab's other current liabilities is $6.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.